Lv1
38 积分 2023-11-13 加入
AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma
2个月前
已完结
Quality of life of patients with hematological malignancies and factors affecting health state utility values
3个月前
已完结
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives
3个月前
已完结
Mechanisms of HBV-induced hepatocellular carcinoma
6个月前
已完结
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial
11个月前
已完结
Cost-effectiveness of anti-BCMA chimeric antigen receptor T cell therapy in relapsed/ refractory multiple myeloma
1年前
已完结
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
1年前
已完结
皖公网安备34019202002308
